• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对单独用于经椎间孔腰椎椎间融合术的MagnetOs Easypack骨水泥的回顾性研究。

A retrospective review of MagnetOs Easypack Putty bone graft used standalone in transforaminal lumbar interbody fusion.

作者信息

Davis Justin, Everist Brian, Hatfield Casey, Sage Katherine

机构信息

Neurosurgery The University of Kansas Health System.

Radiology The University of Kansas Health System.

出版信息

Orthop Rev (Pavia). 2025 Apr 29;17:133986. doi: 10.52965/001c.133986. eCollection 2025.

DOI:10.52965/001c.133986
PMID:40314038
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12045331/
Abstract

BACKGROUND

Spinal fusion surgeries remain a successful treatment for degenerative disc disease. While autograft is considered the gold standard bone graft, synthetic bone void fillers are increasingly used to limit donor site morbidity while giving sufficient graft volume.

METHODS

This retrospective clinical study evaluates MagnetOs Easypack Putty as a standalone graft without autograft in interbody fusion. An independent radiologist blinded to the clinical status provided evaluation of computed tomography (CT) images obtained at 12 months and graded each treated level based on the Brantigan-Steffee-Fraser (BSF) Classification. Twenty subjects were enrolled in the study. A total of 36 spinal levels were treated with an average of 1.8 levels per subject (L2-L3 to L5-S1).

RESULTS

The primary endpoint of CT-based fusion was 94.4% (34/36 levels) based on the presence of bridging bone or locked pseudoarthrosis at 12 months. The high fusion rate was accompanied by consistent improvement in pain scores. Visual analogue scale (VAS) pain scores decreased an average of 25% from 5.3/10 pre-operatively to 2.8/10 at 12 months post-operative, and all subjects who reported pre-operative back or leg pain reported improved pain post-operatively. Although the patient population included risk factors and comorbidities, the fusion rate remained high, and no device-related adverse events (AEs) were observed.

CONCLUSIONS

The high fusion rate and favorable safety profile support the performance of MagnetOs Easypack Putty for standalone use without autograft in interbody fusion procedures.

摘要

背景

脊柱融合手术仍然是治疗椎间盘退变疾病的一种成功方法。虽然自体骨移植被认为是骨移植的金标准,但合成骨缺损填充材料越来越多地被用于限制供体部位的发病率,同时提供足够的移植量。

方法

这项回顾性临床研究评估了MagnetOs Easypack 油灰作为椎间融合中无需自体骨的独立移植材料。一位对临床状况不知情的独立放射科医生对在12个月时获得的计算机断层扫描(CT)图像进行评估,并根据布兰特igan-斯特菲-弗雷泽(BSF)分类对每个治疗节段进行分级。共有20名受试者参与了该研究。总共治疗了36个脊柱节段,每位受试者平均治疗1.8个节段(L2-L3至L5-S1)。

结果

基于12个月时桥接骨的存在或锁定假关节,基于CT的融合的主要终点为94.4%(34/36个节段)。高融合率伴随着疼痛评分的持续改善。视觉模拟量表(VAS)疼痛评分从术前的5.3/10平均下降了25%,至术后12个月时为2.8/10,所有术前报告有背部或腿部疼痛的受试者术后疼痛均有所改善。尽管患者群体包括风险因素和合并症,但融合率仍然很高,且未观察到与器械相关的不良事件(AE)。

结论

高融合率和良好的安全性支持MagnetOs Easypack油灰在椎间融合手术中无需自体骨独立使用的性能。

相似文献

1
A retrospective review of MagnetOs Easypack Putty bone graft used standalone in transforaminal lumbar interbody fusion.对单独用于经椎间孔腰椎椎间融合术的MagnetOs Easypack骨水泥的回顾性研究。
Orthop Rev (Pavia). 2025 Apr 29;17:133986. doi: 10.52965/001c.133986. eCollection 2025.
2
Clinical experience with the use of a spherical bioactive glass putty for cervical and lumbar interbody fusion.使用球形生物活性玻璃糊剂进行颈椎和腰椎椎间融合的临床经验。
J Spine Surg. 2020 Mar;6(1):49-61. doi: 10.21037/jss.2020.03.06.
3
Promotion of higher rates of early fusion using activated titanium versus polyetheretherketone cages in adults undergoing 1- and 2-level transforaminal lumbar interbody fusion procedures: a randomized controlled trial.使用钛活化与聚醚醚酮笼在成人进行 1 到 2 个节段经椎间孔腰椎融合术中促进早期融合率:一项随机对照试验。
J Neurosurg Spine. 2023 Aug 4;39(5):709-718. doi: 10.3171/2023.6.SPINE23382. Print 2023 Nov 1.
4
Results of lumbar spondylodeses using different bone grafting materials after transforaminal lumbar interbody fusion (TLIF).经椎间孔腰椎体间融合(TLIF)后使用不同植骨材料的腰椎融合术的结果。
Eur Spine J. 2017 Nov;26(11):2835-2842. doi: 10.1007/s00586-017-5145-0. Epub 2017 May 25.
5
Randomized clinical trial: expanded autologous bone marrow mesenchymal cells combined with allogeneic bone tissue, compared with autologous iliac crest graft in lumbar fusion surgery.随机临床试验:与自体髂嵴植骨相比,扩增自体骨髓间充质细胞联合同种异体骨组织在腰椎融合术中的应用。
Spine J. 2020 Dec;20(12):1899-1910. doi: 10.1016/j.spinee.2020.07.014. Epub 2020 Jul 28.
6
The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study.OP-1(重组人骨形态发生蛋白-7)替代髂嵴自体骨用于腰椎后外侧融合术的安全性和有效性:一项初步研究的至少4年随访
Spine J. 2008 May-Jun;8(3):457-65. doi: 10.1016/j.spinee.2007.03.012. Epub 2007 May 25.
7
Bilateral implantation of low-profile interbody fusion cages: subsidence, lordosis, and fusion analysis.双侧植入低轮廓椎间融合器:下沉、前凸及融合分析。
Spine J. 2003 Sep-Oct;3(5):377-87. doi: 10.1016/s1529-9430(03)00145-1.
8
[Comparison of effectiveness between unilateral biportal endoscopic lumbar interbody fusion and endoscopic transforaminal lumbar interbody fusion for lumbar spinal stenosis combined with intervertebral disc herniation].单侧双通道内镜下腰椎椎间融合术与内镜下经椎间孔腰椎椎间融合术治疗腰椎管狭窄症合并椎间盘突出症的疗效比较
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2023 Sep 15;37(9):1098-1105. doi: 10.7507/1002-1892.202303095.
9
Combining Expandable Interbody Cage Technology With a Minimally Invasive Technique to Harvest Iliac Crest Autograft Bone to Optimize Fusion Outcomes in Minimally Invasive Transforaminal Lumbar Interbody Fusion Surgery.将可扩张椎间融合器技术与微创技术相结合,以获取髂嵴自体骨,从而优化微创经椎间孔腰椎间融合术的融合效果。
Clin Spine Surg. 2021 Nov 1;34(9):E522-E530. doi: 10.1097/BSD.0000000000001228.
10
Minimally Invasive Transforaminal Versus Lateral Lumbar Interbody Fusion for Degenerative Spinal Pathology: Clinical Outcome Comparison in Patients With Predominant Back Pain.微创经椎间孔腰椎体间融合术与侧方腰椎体间融合术治疗退行性脊柱病变:以腰痛为主诉患者的临床疗效比较。
Clin Spine Surg. 2024 Dec 1;37(10):E441-E447. doi: 10.1097/BSD.0000000000001631. Epub 2024 Oct 25.

本文引用的文献

1
Ceramic bone graft substitute vs autograft in XLIF: a prospective randomized single-center evaluation of radiographic and clinical outcomes.陶瓷骨移植物替代物与自体骨在 XLIF 中的比较:前瞻性随机单中心评估影像学和临床结果。
Eur Spine J. 2022 Sep;31(9):2262-2269. doi: 10.1007/s00586-022-07275-y. Epub 2022 Jun 20.
2
Biphasic calcium phosphate with submicron surface topography in an model of instrumented posterolateral spinal fusion.在器械辅助后外侧脊柱融合模型中具有亚微米表面形貌的双相磷酸钙
JOR Spine. 2018 Nov 28;1(4):e1039. doi: 10.1002/jsp2.1039. eCollection 2018 Dec.
3
Accelerated bone formation by biphasic calcium phosphate with a novel sub-micron surface topography.新型亚微米表面形貌双相磷酸钙促进骨形成。
Eur Cell Mater. 2019 Jan 28;37:60-73. doi: 10.22203/eCM.v037a05.
4
Posterolateral fusion (PLF) versus transforaminal lumbar interbody fusion (TLIF) for spondylolisthesis: a systematic review and meta-analysis.后路融合术(PLF)与经椎间孔腰椎间融合术(TLIF)治疗腰椎滑脱症的系统评价和 Meta 分析。
Spine J. 2018 Jun;18(6):1088-1098. doi: 10.1016/j.spinee.2018.01.028. Epub 2018 Feb 13.
5
Minimally Invasive Transforaminal Lumbar Interbody Fusion: Meta-analysis of the Fusion Rates. What is the Optimal Graft Material?微创经椎间孔腰椎体间融合术:融合率的荟萃分析。最佳移植物材料是什么?
Neurosurgery. 2017 Dec 1;81(6):958-971. doi: 10.1093/neuros/nyx141.
6
Fusion rate following extreme lateral lumbar interbody fusion.极外侧腰椎椎间融合术后的融合率
Eur Spine J. 2015 Apr;24 Suppl 3:369-71. doi: 10.1007/s00586-015-3929-7. Epub 2015 Apr 17.
7
Twelve-month results of a multicenter, blinded, pilot study of a novel peptide (B2A) in promoting lumbar spine fusion.一项关于新型肽(B2A)促进腰椎融合的多中心、盲法试点研究的12个月结果。
J Neurosurg Spine. 2015 Apr;22(4):358-66. doi: 10.3171/2013.11.SPINE121106. Epub 2015 Jan 23.
8
Iliac crest bone graft donor site pain after anterior lumbar interbody fusion: a prospective patient satisfaction outcome assessment.腰椎前路椎间融合术后髂嵴骨移植供区疼痛:一项前瞻性患者满意度结果评估。
J Spinal Disord Tech. 2005 Feb;18 Suppl:S77-81. doi: 10.1097/01.bsd.0000112045.36255.83.
9
Complications of iliac crest bone graft harvesting.髂嵴取骨的并发症。
Clin Orthop Relat Res. 1996 Aug(329):300-9. doi: 10.1097/00003086-199608000-00037.
10
Morbidity at bone graft donor sites.骨移植供体部位的发病率。
J Orthop Trauma. 1989;3(3):192-5. doi: 10.1097/00005131-198909000-00002.